🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/02/2006 60,05 61,74 60,05 61,08 +1,31% 2,81% 592.000
06/02/2006 59,29 60,49 59,08 60,29 +1,45% 2,38% 515.900
03/02/2006 60,04 60,04 58,73 59,43 -1,28% 2,18% 631.500
02/02/2006 60,96 61,40 59,76 60,20 -1,25% 2,69% 872.200
01/02/2006 60,62 61,30 60,52 60,96 +0,31% 1,29% 420.200
31/01/2006 60,88 61,25 59,85 60,77 -0,33% 2,30% 565.900
30/01/2006 61,54 61,71 60,90 60,97 -0,85% 1,32% 507.600
27/01/2006 60,66 61,52 60,28 61,49 +1,60% 2,04% 448.900
26/01/2006 60,56 60,84 59,75 60,52 +0,45% 1,80% 470.500
25/01/2006 61,83 61,87 59,75 60,25 -1,70% 3,43% 505.600
24/01/2006 61,47 61,74 59,75 61,29 +1,59% 3,24% 791.900
23/01/2006 59,67 60,58 58,54 60,33 +0,60% 3,42% 919.900
20/01/2006 61,10 61,50 59,63 59,97 -1,61% 3,06% 505.900
19/01/2006 59,40 61,50 59,15 60,95 +2,70% 3,96% 745.300
18/01/2006 58,63 59,62 57,45 59,35 +0,36% 3,70% 992.800
17/01/2006 60,48 60,78 59,13 59,14 -3,05% 2,73% 929.600
13/01/2006 61,29 61,50 60,76 61,00 -0,68% 1,21% 422.600
12/01/2006 63,67 63,67 61,25 61,42 -2,45% 3,80% 718.900
11/01/2006 63,40 64,85 61,77 62,96 -2,37% 4,86% 1.490.400
10/01/2006 64,50 65,54 64,06 64,49 -0,42% 2,29% 515.200
09/01/2006 64,47 64,90 63,57 64,76 +1,09% 2,06% 556.200
06/01/2006 63,10 64,86 62,96 64,06 +1,68% 3,01% 629.300
05/01/2006 63,92 63,99 62,35 63,00 -0,94% 2,57% 941.800
04/01/2006 64,27 64,65 63,57 63,60 +0,05% 1,68% 993.300
03/01/2006 63,35 64,10 60,89 63,57 +1,34% 5,07% 525.700
30/12/2005 62,89 63,08 62,29 62,73 -0,52% 1,26% 170.100
29/12/2005 63,94 63,94 62,85 63,06 -1,38% 1,70% 273.200
28/12/2005 63,97 64,43 63,57 63,94 -0,16% 1,34% 191.000
27/12/2005 64,35 65,24 63,68 64,04 -0,33% 2,42% 332.500
23/12/2005 64,23 64,81 63,87 64,25 +0,08% 1,46% 110.200